Jun 2026 (Q2 FY26) — Jul 29, 2026
Teladoc Health Q2 FY26 — BetterHelp Pivots to Insurance, Integrated Care Stable
Read the full callTeladoc Health (TDOC) earnings
- Jun 2026
- Jun 2026 (Q2 FY26)
- Dec 2025
Teladoc Health earnings: last reported Wed, 29 Jul 2026, for the quarter ended Jun 2026.
Reported
The figures, each with its period
Each figure keeps its basis and period; nothing is filled in.
| Metric | Value | Change | Basis | Period | Note |
|---|---|---|---|---|---|
| Revenue | 607 | −4.0% YoY | Quarterly, as filed | Quarter to Jun 2026 | Revenue from operations as filed. |
| Operating margin | -6.1 | +2.5 pts YoY | Operating profit / revenue | Quarter to Jun 2026 | For the quarter; a change is in percentage points. |
| Net profit | -38.9 | Quarterly, as filed | Quarter to Jun 2026 | Profit after tax as filed. The year-earlier figure was zero or a loss, so no percentage is shown. |
Price
$5.73 +1.06% · +$0.06
Performance −32.8% 1Y
1Y: $8.53 on 17 Oct 2025 → $5.73. High $9.72 (15 Jul 2026), low $4.47 (12 Feb 2026).
- Previous close
- $5.67
- 52-week range
- $4.47 – $9.72
- One year
- −36.19%
Overview
- Symbol
- TDOC
- Sector
- Health Care
- Exchange
- US
- Currency
- USD
Call summaries
Every analysed call
Teladoc Health earnings calls (TDOC)
Financials
What the filings say
Net profit, year on year: −19% (quarter to jun 2026 against jun 2025).
| Line item | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|
| Sales | 641 | 640 | 629 | 632 | 626 | 642 | 614 | 607 |
| Expenses | 685 | 689 | 750 | 686 | 678 | 678 | 676 | 644 |
| Operating profit | -44 | -48 | -121 | -54 | -52 | -36 | -62 | -37 |
| Operating margin | −6.9% | −7.5% | −19.2% | −8.6% | −8.3% | −5.6% | −10.1% | −6.1% |
| Interest | 6 | 7 | 6 | 4 | 5 | 5 | 5 | 5 |
| Profit before tax | -32 | -48 | -111 | -40 | -50 | -34 | -61 | -38 |
| Tax rate | −2.4% | −0.5% | 16.4% | 19.2% | 1.4% | 25.2% | −4.9% | −2.6% |
| Net profit | -33 | -48 | -93 | -33 | -50 | -25 | -64 | -39 |
| EPS ($ per share) | -0.19 | — | -0.53 | -0.19 | -0.28 | — | -0.36 | -0.21 |
| Line item | Dec 2018 | Dec 2019 | Dec 2020 | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|---|---|---|
| Equity capital | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Reserves | -409 | -508 | -993 | -1,421 | -15,008 | -15,229 | -16,230 | -16,430 |
| Total liabilities | 516 | 589 | 1,871 | 1,689 | 2,038 | 2,066 | 2,025 | 1,473 |
| Fixed assets | 10 | 10 | 29 | 27 | 30 | 32 | 29 | 27 |
| Total assets | 1,529 | 1,603 | 17,755 | 17,735 | 4,345 | 4,392 | 3,517 | 2,858 |
| Line item | Dec 2018 | Dec 2019 | Dec 2020 | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|---|---|---|
| Cash from operations | -5 | 30 | -54 | 194 | 189 | 350 | 294 | 294 |
| Cash from investing | -257 | 25 | -591 | -73 | -168 | -156 | -124 | -266 |
| Cash from financing | 646 | 35 | 859 | 41 | 6 | 11 | 8 | -552 |
| Net cash flow | 383 | — | — | — | — | — | — | — |
| Capital expenditure | -4 | -4 | -4 | -9 | -16 | -11 | -11 | -9 |
| Free cash flow | -9 | 26 | -58 | 185 | 173 | 339 | 283 | 285 |
Insider filings
114 filings between Nov 14, 2025 and Oct 2, 2026.
Open market
decisions to buy or sellPurchases
$69.4K
1 purchase by 1 insider
Sales
$2.39M
37 sales by 6 insiders
27% filed under a 10b5-1 plan — scheduled in advance, not decided on the day
Compensation
not trading decisions- 76
- Option exercise — converted options into shares
Who traded
open market only| Insider | Bought | Sold | Last filing |
|---|---|---|---|
| DIVITA CHARLES III | — | $1.04M | Sep 11, 2026 |
| Rodrigues Fernando M. | — | $469.6K | Sep 3, 2026 |
| Bliss Kelly | — | $343.1K | Sep 2, 2026 |
| Vandervoort Adam C | — | $289.4K | Sep 2, 2026 |
| Nueno Carlos | — | $218.7K | Sep 2, 2026 |
| Paulus Kenneth H | $69.4K | — | Nov 14, 2025 |
| Catapano Joseph Ronald | — | $29.2K | Oct 2, 2026 |
Latest filings (50)
| Date | Insider | What | Shares | Value |
|---|---|---|---|---|
| Oct 2, 2026 | Catapano Joseph Ronald Chief Accounting Officer | Sale | 655 | $3.7K |
| Oct 1, 2026 | Catapano Joseph Ronald Chief Accounting Officer | Option exercise | 2,083 | — |
| Sep 11, 2026 | DIVITA CHARLES III CHIEF EXECUTIVE OFFICER | Sale | 17,805 | $108.7K |
| Sep 10, 2026 | DIVITA CHARLES III CHIEF EXECUTIVE OFFICER | Option exercise | 3,642 | — |
| Sep 10, 2026 | DIVITA CHARLES III CHIEF EXECUTIVE OFFICER | Option exercise | 39,160 | — |
| Sep 3, 2026 | Rodrigues Fernando M. President of BetterHelp | Sale 10b5-1 plan | 9,812 | $63.9K |
| Sep 2, 2026 | Vandervoort Adam C CHIEF LEGAL OFFICER, SECRETARY | Sale | 7,573 | $47.7K |
| Sep 2, 2026 | DIVITA CHARLES III CHIEF EXECUTIVE OFFICER | Sale | 18,327 | $115.5K |
| Sep 2, 2026 | Bliss Kelly President, U.S. Group Health | Sale | 7,357 | $46.4K |
| Sep 2, 2026 | Catapano Joseph Ronald Chief Accounting Officer | Sale | 274 | $1.7K |
| Sep 2, 2026 | Nueno Carlos President, International | Sale | 6,200 | $39.1K |
| Sep 2, 2026 | Rodrigues Fernando M. President of BetterHelp | Sale 10b5-1 plan | 5,439 | $34.3K |
| Sep 1, 2026 | Bliss Kelly President, U.S. Group Health | Option exercise | 4,859 | — |
| Sep 1, 2026 | Rodrigues Fernando M. President of BetterHelp | Option exercise 10b5-1 plan | 5,492 | — |
| Sep 1, 2026 | Vandervoort Adam C CHIEF LEGAL OFFICER, SECRETARY | Option exercise | 5,350 | — |
| Sep 1, 2026 | Bliss Kelly President, U.S. Group Health | Option exercise | 1,300 | — |
| Sep 1, 2026 | Catapano Joseph Ronald Chief Accounting Officer | Option exercise | 39 | — |
| Sep 1, 2026 | DIVITA CHARLES III CHIEF EXECUTIVE OFFICER | Option exercise | 1,966 | — |
| Sep 1, 2026 | Bliss Kelly President, U.S. Group Health | Option exercise | 9,152 | — |
| Sep 1, 2026 | Nueno Carlos President, International | Option exercise | 4,556 | — |
| Sep 1, 2026 | Catapano Joseph Ronald Chief Accounting Officer | Option exercise | 833 | — |
| Sep 1, 2026 | Vandervoort Adam C CHIEF LEGAL OFFICER, SECRETARY | Option exercise | 426 | — |
| Sep 1, 2026 | Rodrigues Fernando M. President of BetterHelp | Option exercise 10b5-1 plan | 8,717 | — |
| Sep 1, 2026 | Nueno Carlos President, International | Option exercise | 8,717 | — |
| Sep 1, 2026 | Rodrigues Fernando M. President of BetterHelp | Option exercise 10b5-1 plan | 1,042 | — |
| Sep 1, 2026 | DIVITA CHARLES III CHIEF EXECUTIVE OFFICER | Option exercise | 42,277 | — |
| Sep 1, 2026 | Vandervoort Adam C CHIEF LEGAL OFFICER, SECRETARY | Option exercise | 9,152 | — |
| Jul 6, 2026 | Bliss Kelly President, U.S. Group Health | Sale 10b5-1 plan | 2,500 | $23.8K |
| Jul 2, 2026 | Catapano Joseph Ronald Chief Accounting Officer | Sale | 653 | $5.9K |
| Jul 1, 2026 | Catapano Joseph Ronald Chief Accounting Officer | Option exercise | 2,083 | — |
| Jul 1, 2026 | Bliss Kelly President, U.S. Group Health | Sale 10b5-1 plan | 2,500 | $22.5K |
| Jun 29, 2026 | Bliss Kelly President, U.S. Group Health | Sale 10b5-1 plan | 2,500 | $21.3K |
| Jun 11, 2026 | DIVITA CHARLES III CHIEF EXECUTIVE OFFICER | Sale | 18,074 | $125.5K |
| Jun 10, 2026 | DIVITA CHARLES III CHIEF EXECUTIVE OFFICER | Option exercise | 39,160 | — |
| Jun 10, 2026 | DIVITA CHARLES III CHIEF EXECUTIVE OFFICER | Option exercise | 3,642 | — |
| Jun 3, 2026 | Rodrigues Fernando M. President of BetterHelp | Sale 10b5-1 plan | 9,572 | $70.8K |
| Jun 2, 2026 | Nueno Carlos President, International | Sale | 6,196 | $47.3K |
| Jun 2, 2026 | Catapano Joseph Ronald Chief Accounting Officer | Sale | 284 | $2.2K |
| Jun 2, 2026 | Vandervoort Adam C CHIEF LEGAL OFFICER, SECRETARY | Sale | 7,906 | $60.3K |
| Jun 2, 2026 | DIVITA CHARLES III CHIEF EXECUTIVE OFFICER | Sale | 19,132 | $145.9K |
| Jun 2, 2026 | Rodrigues Fernando M. President of BetterHelp | Sale | 5,677 | $43.3K |
| Jun 2, 2026 | Bliss Kelly President, U.S. Group Health | Sale | 7,679 | $58.6K |
| Jun 1, 2026 | Bliss Kelly President, U.S. Group Health | Option exercise | 4,858 | — |
| Jun 1, 2026 | Bliss Kelly President, U.S. Group Health | Option exercise | 9,152 | — |
| Jun 1, 2026 | Bliss Kelly President, U.S. Group Health | Option exercise | 1,300 | — |
| Jun 1, 2026 | Nueno Carlos President, International | Option exercise | 4,556 | — |
| Jun 1, 2026 | Catapano Joseph Ronald Chief Accounting Officer | Option exercise | 833 | — |
| Jun 1, 2026 | Catapano Joseph Ronald Chief Accounting Officer | Option exercise | 39 | — |
| Jun 1, 2026 | Rodrigues Fernando M. President of BetterHelp | Option exercise | 8,716 | — |
| Jun 1, 2026 | Vandervoort Adam C CHIEF LEGAL OFFICER, SECRETARY | Option exercise | 9,152 | — |
Source: SEC Form 4 filings. Form 4 reports transactions, not the cap table — absence of filings says nothing about how much an insider owns, and a quiet window is not a signal.
Your own record
Start an Inve Case for Teladoc Health, Inc.
Free account. Everything above stays public.
Write why you follow Teladoc Health, Inc. and the condition you want checked. Inve compares your numeric conditions with available results and management guidance; your own conditions remain yours to review.
Keep reading